Moreover, trabectedin exerts a significant influence on the tumor microenvironment (TME), inducing a downregulation in the expression of pro-inflammatory and pro-angiogenetic cytokines such as IL-6, angiopoietin 2 (Ang-2), and vascular endothelial growth factor (VEGF) [4]. Here, ANGPT2 is linked to neoplasm.